Clinical Trial Update: The Response To Ajmaline Provocation in Healthy Subjects [Phase 2]

View source ↗

Summary

Phase 2 clinical trial updating response to ajmaline provocation in healthy subjects, with conditions including Brugada Syndrome and Sudden Death.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brugada Syndrome
• Sudden Death

Drugs mentioned

• Ajmaline (ajmaline)

Snippet

Sponsor: St George's, University of London | Conditions: Brugada Syndrome, Sudden Death | Phase 2 | Status: UNKNOWN